Nurexa-NT Tablet is a combination pharmaceutical formulation containing Pregabalin 75mg, Nortriptyline 10mg, and Methylcobalamin 1500mcg, designed for the management of neuropathic pain and associated neurological conditions. Pregabalin, a gamma-aminobutyric acid (GABA) analogue, exerts its effect by modulating calcium channels in the central nervous system, thereby reducing neuronal excitability and alleviating neuropathic pain symptoms. Nortriptyline, a tricyclic antidepressant, contributes analgesic properties through inhibition of norepinephrine and serotonin reuptake, enhancing descending inhibitory pain pathways. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair by promoting myelin sheath synthesis and neurotrophic activity. The synergistic action of these components provides effective relief from chronic neuropathic pain, including diabetic neuropathy, postherpetic neuralgia, and peripheral neuropathies. Nurexa-NT is typically prescribed as part of a comprehensive pain management regimen and should be administered under medical supervision, considering potential contraindications and side effects such as dizziness, dry mouth, or gastrointestinal disturbances. Regular monitoring is advised to assess therapeutic response and tolerability. This combination therapy aims to improve patient quality of life by addressing both symptomatic pain relief and underlying nerve health.